Summary. Type II alveolar lung cells metabolize polycyclic aromatic hydrocarbons as indicated by measurements of aryl hydrocarbon hydroxylase activity and binding of tritium labeled benzo(a)pyrene to nuclear and cytoplasmic components.
Materials and methods.
Type II alveolar pneumonocytes (L-2) were maintained in vitro in Ham's modified F12K medium supplemented with 10% fetal bovine serum at 37 ~ in a humidified atmosphere of 5% Co 2 in air. L-2 cells at population doubling levels 26 and 27 were grown to confluency and fed fresh medium to which either benzo(a)-pyrene (BP), 9,10-dimethyl 1,2-benzanthracene or 3-methylcholanthrene at a final concentration of 2 gg/ml was added. After 24 h cells were washed with buffered saline and aryl hydrocarbon hydroxylase (AHH) activity was determined by fluorometric measurements of water soluble metabolites as described 7'8. AHH activity was expressed as units/gg DNA where 1 unit was defined as that amount of activity producing hydroxylated products equal in fluorescence to 1 pmole of 3-h~droxybenzo(a)pyrene 7. DNA was quantitated as describe&. L-2 cells exposed for 24 h to 3H-BP (sp. act. 25.2 Ci/mM) at a final concentration of 2 gCi/ml were washed and homogenized to yield free intact nuclei. Nuclei were solubilized and aliquots counted in 10 ml scintillant in a Beckman LS-230 liquid scintillation counter. Bound label was expressed as cpm per gg DNA. Unbound label was removed from the cytoplas- L-2 cells were exposed to one of 3 polycyclic aromatic hydrocarbons for 24 h at a concentration of 2 gg/ml culture medium. Fluorescence of water-soluble product was determined and activity expressed as units/gg DNA. Assays were run in triplicate. The target sites for ultimate carcinogen action are thought to involve nuclear macromolecules 13. Binding of 3H-BP metabolites to DNA, RNA, and nuclear proteins has been described ~4. Current studies are underway to examine the binding of 3H-BP to specific nuclear macromolecules in L-2 cells. It is not known whether binding of BP to cytoplasmic receptors is a prerequisite to nuclear binding but it has been suggested that cytoplasmic protein receptors could function to facilitate carcinogen transport to nuclear receptor sites 9. Interaction with critical macromolecules could then initiate the cellular events associated with transformation.
In conclusion these studies indicate that type II alveolar lung cells possess the enzyme machinery for PAH metabolism and that nuclear and cytoplasmic receptors bind BP. The relationship of PAH metabolism in type II cells to lung carcinogenesis is yet to be illucidated.
